Schizophrenia-Psychotic Disorders & Antipsychotics

 (Haga un click en la información del journal para acceder al resúmen)

5 – doble-ciego o metanálisis; 4 – subanálisis o simple ciego; 3 – revisión, abierto, básico; 2 – casos; 1 – opinión

 

3! - Beyond the critical period: longitudinal study of 8-year outcome in first-episode non-affective psychosis

Niall Crumlish, Peter Whitty, Mary Clarke, Stephen Browne, Moayyad Kamali, Maurice Gervin, Orfhlaith McTigue, Anthony Kinsella, John L Waddington, Conall Larkin, Eadbhard O’Callaghan

The British Journal of Psychiatry (2009) 194: 18-24

5 - Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis

Stefan Leucht, Caroline Corves, Dieter Arbter, Rolf R Engel, Chunbo Li and Prof John M Davis

The Lancet. Volume 373, Issue 9657, 3 January 2009-9 January 2009, Pages 31-41

 

3! - Long-Term Outcome of Leucotomy On Behaviour of People With Schizophrenia

Edward Helmes, Varadaraj R. Velamoor

International Journal of Social Psychiatry, Vol. 55, No. 1, 64-70 (2009)

3 - Activation of metabotropic glutamate receptors as a novel approach for the treatment of schizophrenia

P. Jeffrey Conn, Craig W. Lindsley and Carrie K. Jones

Trends in Pharmacological Sciences. Volume 30, Issue 1, January 2009, Pages 25-31

 

3 - Results of phase 3 of the CATIE schizophrenia trial

T. Scott Stroup, Jeffrey A. Lieberman, Joseph P. McEvoy, Sonia M. Davis, Marvin S. Swartz, Richard S.E. Keefe, Alexander L. Miller, Robert A. Rosenheck, John K. Hsiao and for the CATIE Investigators

Schizophrenia Research. Volume 107, Issue 1, January 2009, Pages 1-12

 

4 - Does switching to a new antipsychotic improve outcomes?: Data from the CATIE Trial

Robert A Rosenheck, Sonia Davis, Nancy Covell, Susan Essock, Marvin Swartz, Scott Stroup, Joseph McEvoy and Jeffrey Lieberman

Schizophrenia Research. Volume 107, Issue 1, January 2009, Pages 22-29

 

3 - Comparing Acute Toxicity of First- and Second-Generation Antipsychotic Drugs: A 10-Year, Retrospective Cohort Study

Michael A. Ciranni, Thomas E. Kearney, and Kent R. Olson

J Clin Psychiatry January 13, 2009: e1-e8

 

3 - Mortality Rates Among Patients With Schizophrenia and Tardive Dyskinesia

Chong, Siow-Ann; Tay, Jenny A.M; Subramaniam, Mythily; Pek, Elaine; Machin, David

Journal of Clinical Psychopharmacology. 29(1):5-8, February 2009

3! - HTR2C Gene Polymorphisms and the Metabolic Syndrome in Patients With Schizophrenia: A Replication Study

Mulder, Hans; Cohen, Dan; Scheffer, Hans; Gispen-de Wied, Christine; Arends, Johan; Wilmink, Frederik W; Franke, Barbara; Egberts, Antoine C.G

Journal of Clinical Psychopharmacology. 29(1):16-20, February 2009

3 - Polymorphisms of the LEP- and LEPR Gene and Obesity in Patients Using Antipsychotic Medication

Gregoor, Jochem G; van der Weide, Jan; Mulder, Hans; Cohen, Dan; van Megen, Harold J.G.M; Egberts, Antoine C.G; Heerdink, Eibert R

Journal of Clinical Psychopharmacology. 29(1):21-25, February 2009

3 - Association Between HTR2C and HTR2A Polymorphisms and Metabolic Abnormalities in Patients Treated With Olanzapine or Clozapine

Gunes, Arzu; Melkersson, Kristina I; Scordo, Maria Gabriella; Dahl, Marja-Liisa

Journal of Clinical Psychopharmacology. 29(1):65-68, February 2009

3 - GABA_A receptors in nucleus accumbens shell mediate the hyperphagia and weight gain following haloperidol treatment in rats

Harsahay Meena, Kartik T. Nakhate, Dadasaheb M. Kokare and Nishikant K. Subhedar

Life Sciences. Volume 84, Issues 5-6, 30 January 2009, Pages 156-163   

 

3 - Atypical neuroleptic risperidone modulates glial functions in C6 astroglial cells

André Quincozes-Santos, Larissa Daniele Bobermin, Juliana Kleinkauf-Rocha, Diogo Onofre Souza, Rudimar Riesgo, Carlos-Alberto Gonçalves and Carmem Gottfried

Progress in Neuro-Psychopharmacology and Biological Psychiatry. Volume 33, Issue 1, 1 February 2009, Pages 11-15

 

3! - Schizophrenia with prominent catatonic features (‘catatonic schizophrenia’): III. Latent class analysis of the catatonic syndrome

Gabor S. Ungvari, William Goggins, Siu-Kau Leung, Edwin Lee and Jozsef Gerevich

Progress in Neuro-Psychopharmacology and Biological Psychiatry. Volume 33, Issue 1, 1 February 2009, Pages 81-85

 

GRATIS 3! - Atypical Antipsychotic Drugs and the Risk of Sudden Cardiac Death

Wayne A. Ray, Cecilia P. Chung, Katherine T. Murray, Kathi Hall, and C. Michael Stein

NEJM. 2009; Volume 360:225-235

 

3! - Long-term efficacy and safety of aripiprazole in patients with schizophrenia, schizophreniform disorder, or schizoaffective disorder: 26-week prospective study

Jun Soo Kwon, Joon Hwan Jang, Do-Hyung Kang, So Young Yoo, Yong Ku Kim, Seong-Jin Cho, and the APLUS study group

Psychiatry and Clinical Neurosciences. Volume 63 Issue 1, Pages 73 - 81

 

5< - Rosiglitazone in the Assistance of Metabolic Control during Olanzapine Administration in Schizophrenia: A Pilot Double-blind, Placebo-controlled, 12-week Trial

T. Baptista, N. Rangel, Y. El Fakih, E. Uzcátegui, T. Galeazzi,S. Beaulieu, E. Araujo de Baptista

Pharmacopsychiatry 2009; 42: 14-19

3< - Effects of Six Second Generation Antipsychotics on Body Weight and Metabolism - Risk Assessment and Results from a Prospective Study

A. Tschoner, J. Engl, M. Rettenbacher, M. Edlinger, S. Kaser,T. Tatarczyk, M. Effenberger, J. R. Patsch, W. W. Fleischhacker,C. F. Ebenbichler

Pharmacopsychiatry 2009; 42: 29-34

3 - Obsessive-compulsive disorder in UK clozapine-treated schizophrenia and schizoaffective disorder: a cause for clinical concern

K. Mukhopadhaya, R. Krishnaiah, T. Taye, A. Nigam, AJ Bailey, T. Sivakumaran, NA Fineberg

Journal of Psychopharmacology, Vol. 23, No. 1, 6-13 (2009)

3 - Asenapine: a novel psychopharmacologic agent with a unique human receptor signature

M. Shahid, GB Walker, SH Zorn

Journal of Psychopharmacology, Vol. 23, No. 1, 65-73 (2009)

3 - Oral versus injectable antipsychotic treatment in early psychosis: Post hoc comparison of two studies

Robin Emsley, Petrus Oosthuizen, Liezl Koen, Dana J.H. Niehaus, Rossella Medori and Jonathan Rabinowitz

Clinical Therapeutics. Volume 30, Issue 12, December 2008, Pages 2378-2386

 

3! - Glucose and lipid disturbances after 1 year of antipsychotic treatment in a drug-naïve population

References and further reading may be available for this article. To view references and further reading you must purchase this article.

Rocio Perez-Iglesias, Ignacio Mata, Jose M. Pelayo-Teran, Jose A. Amado, Maria T. Garcia-Unzueta, Ana Berja, Obdulia Martinez-Garcia, Jose L. Vazquez-Barquero and Benedicto Crespo-Facorro

Schizophrenia Research. Volume 107, Issues 2-3, February 2009, Pages 115-121

 

3! - Differences in glucose tolerance between deficit and nondeficit schizophrenia

References and further reading may be available for this article. To view references and further reading you must purchase this article.

Brian Kirkpatrick, Emilio Fernandez-Egea, Clemente Garcia-Rizo and Miguel Bernardo

Schizophrenia Research. Volume 107, Issues 2-3, February 2009, Pages 122-127

 

3! - Mortality over a 20-year period in patients with primary polydipsia associated with schizophrenia: A retrospective study

References and further reading may be available for this article. To view references and further reading you must purchase this article.

Emily R. Hawken, Jake M. Crookall, Deirdre Reddick, Richard C. Millson, Roumen Milev and Nicholas Delva

Schizophrenia Research. Volume 107, Issues 2-3, February 2009, Pages 128-133

 

3! - Cardiac-related findings at autopsy in people with severe mental illness treated with clozapine or risperidone

References and further reading may be available for this article. To view references and further reading you must purchase this article.

Deanna L. Kelly, Heidi J. Wehring, Jared Linthicum, Stephanie Feldman, Robert P. McMahon, Raymond C. Love, Tara Wagner, Joo Cheol Shim and David R. Fowler

Schizophrenia Research. Volume 107, Issues 2-3, February 2009, Pages 134-138

 

3! - Medical comorbidity in patients with schizophrenia and alcohol dependence

References and further reading may be available for this article. To view references and further reading you must purchase this article.

Steven L. Batki, Zsuzsa S. Meszaros, Katherine Strutynski, Jacqueline A. Dimmock, Luba Leontieva, Robert Ploutz-Snyder, Kelly Canfield and Rebecca A. Drayer

Schizophrenia Research. Volume 107, Issues 2-3, February 2009, Pages 139-146

 

3 - Fewer neurological soft signs among first episode psychosis patients with heavy cannabis use

References and further reading may be available for this article. To view references and further reading you must purchase this article.

Miguel Ruiz-Veguilla, Manuel Gurpegui, María Luisa Barrigón, Maite Ferrín, Esther Marín, José Luis Rubio, Blanca Gutiérrez, Antonio Pintor and Jorge Cervilla

Schizophrenia Research. Volume 107, Issues 2-3, February 2009, Pages 158-164

 

3! - Course of illness in a sample of 265 patients with first-episode psychosis—Five-year follow-up of the Danish OPUS trial

References and further reading may be available for this article. To view references and further reading you must purchase this article.

Mette Bertelsen, Pia Jeppesen, Lone Petersen, Anne Thorup, Johan Øhlenschlæger, Phuong Le Quach, Torben Østergaard Christensen, Gertrud Krarup, Per Jørgensen and Merete Nordentoft

Schizophrenia Research. Volume 107, Issues 2-3, February 2009, Pages 173-178

 

5 - Added ondansetron for stable schizophrenia: A double blind, placebo controlled trial

References and further reading may be available for this article. To view references and further reading you must purchase this article.

Shahin Akhondzadeh, Neyousha Mohammadi, Maryam Noroozian, Naregs Karamghadiri, Aboulfazl Ghoreishi, Amir-Hossein Jamshidi and Saeedeh Forghani

Schizophrenia Research. Volume 107, Issues 2-3, February 2009, Pages 206-212

 

3! - Effects of aripiprazole on prolactin levels in subjects with schizophrenia during cross-titration with risperidone or olanzapine: Analysis of a randomized, open-label study

References and further reading may be available for this article. To view references and further reading you must purchase this article.

Matthew J. Byerly, Ronald N. Marcus, Quynh-Van Tran, James M. Eudicone, Richard Whitehead and Ross A. Baker

Schizophrenia Research. Volume 107, Issues 2-3, February 2009, Pages 218-222

 

3! - Association between symptomatic remission and functional outcome in first-episode schizophrenia

References and further reading may be available for this article. To view references and further reading you must purchase this article.

Robert Bodén, Johan Sundström, Eva Lindström and Leif Lindström

Schizophrenia Research. Volume 107, Issues 2-3, February 2009, Pages 232-237

 

3! - The serotonin transporter 5-HTTPR polymorphism is associated with current and lifetime depression in persons with chronic psychotic disorders

J. Contreras, L. Hare, B. Camarena, D. Glahn, A. Dassori, R. Medina, S. Contreras, M. Ramirez, R. Armas, R. Munoz, R. Mendoza, H. Raventos, A. Ontiveros, H. Nicolini, R. Palmer, M. Escamilla

Acta Psychiatrica Scandinavica. Volume 119 Issue 2, Pages 117 - 127

 

3 - Cognitive effects of antipsychotic dosage and polypharmacy: a study with the BACS in patients with schizophrenia and schizoaffective disorder

D Élie, M Poirier, JM Chianetta, M Durand, CA Grégoire, and S Grignon

Journal of Psychopharmacology 2009, First published on January 22

 

3 - The uses and outcomes of quetiapine in depressive and bipolar mood disorders in clinical practice

P Shajahan and M Taylor

Journal of Psychopharmacology 2009, First published on January 22

 

3 - Effect of lactational exposure of olanzapine on body weight of mice: a comparative study on neonates of both the sexes during post-natal development

AC Mishra and B Mohanty

Journal of Psychopharmacology 2009, First published on January 22

 

3! - Which comes first: atypical antipsychotic treatment or cardiometabolic risk?

S. M. Stahl, L. Mignon, J. M. Meyer

Acta Psychiatrica Scandinavica. Volume 119 Issue 3, Pages 171 - 179

 

3! - Prospective comparison of course of disability in antipsychotic-treated and untreated schizophrenia patients

J. Thirthalli, B. K. Venkatesh, K. V. Kishorekumar, U. Arunachala, G. Venkatasubramanian, D. K. Subbakrishna, B. N. Gangadhar

Acta Psychiatrica Scandinavica. Volume 119 Issue 3, Pages 209 - 217

 

3 - Violence among schizophrenia out-patients compliant with medication: prevalence and associated factors

J. Bobes, O. Fillat, C. Arango

Acta Psychiatrica Scandinavica. Volume 119 Issue 3, Pages 218 - 225

 

3! - A possible relationship between Toxoplasma gondii and schizophrenia: A seroprevalence study

Funda Dogruman-Al;  Selcuk Aslan;  Safak Yalcin;  Semra Kustimur; Songul Turk

International Journal of Psychiatry in Clinical Practice, Volume 13, Issue 1 March 2009, pages 1 - 6

 

GRATIS 3! - Review: Insufficient evidence to guide use of drugs for clozapine induced hypersalivation
S. Sockalingam and G. Remington
Evid Based Ment Health 2009 12: 12

 

GRATIS 5 - Antipsychotic medications do not differ substantially in ability to reduce violent behaviour in people with schizophrenia
N. H Covell
Evid Based Ment Health 2009 12: 13

 

GRATIS 3! - Maternal use of antipsychotics in early pregnancy: little evidence of increased risk of congenital malformations
A. Einarson and T. R Einarson
Evid Based Ment Health 2009 12: 29

 

3! - Pharmacological Manipulation of Kynurenic Acid: Potential in the Treatment of Psychiatric Disorders

Erhardt, Sophie; Olsson, Sara K.; Engberg, Göran

CNS Drugs:Volume 23(2)2009pp 91-101

 

3! - Global pattern of experienced and anticipated discrimination against people with schizophrenia: a cross-sectional survey

References and further reading may be available for this article. To view references and further reading you must purchase this article.

Graham Thornicroft, Elaine Brohan, Diana Rose, Norman Sartorius, Morven Leese and for the INDIGO Study Group

The Lancet. Volume 373, Issue 9661, 31 January 2009-6 February 2009, Pages 408-415

 

4 - The Acute Efficacy of Aripiprazole Across the Symptom Spectrum of Schizophrenia: A Pooled Post Hoc Analysis From 5 Short-Term Studies

Philip G. Janicak, Ira D. Glick, Stephen R. Marder, David T. Crandall, Robert D. McQuade, Ronald N. Marcus, James M. Eudicone, and Sheila Assunção-Talbott

J Clin Psychiatry 2009;70(1):25-35

 

3! - The Impact of Calories and Fat Content of Meals on Oral Ziprasidone Absorption: A Randomized, Open-Label, Crossover Trial

Kuan Gandelman, Jeffrey A. Alderman, Paul Glue, Ilise Lombardo, Robert R. LaBadie, Mark Versavel, and Sheldon H. Preskorn

J Clin Psychiatry 2009;70(1):58-62

 

3! - Glucose Metabolism in Japanese Schizophrenia Patients Treated With Risperidone or Olanzapine

Norio Yasui-Furukori, Yasushi Sato, Hanako Furukori, Manabu Saito, Taku Nakagami, and Sunao Kaneko

J Clin Psychiatry 2009;70(1):95-100

 

3! - Modafinil as an Adjunctive Treatment of Sedation, Negative Symptoms, and Cognition in Schizophrenia: A Critical Review

Carlos Saavedra-Velez, Anna Yusim, Deepti Anbarasan, and Jean-Pierre Lindenmayer

J Clin Psychiatry 2009;70(1):104-112

 

3 - Comparing Acute Toxicity of First-and Second-Generation Antipsychotic Drugs: A 10-Year, Retrospective Cohort Study

Michael A. Ciranni, Thomas E. Kearney, and Kent R. Olson

J Clin Psychiatry 2009;70(1):122-129

 

GRATIS 3! - Early Predictors of Nonadherence to Antipsychotic Therapy in First-Episode Psychosis

Mark Rabinovitch, Laura Béchard-Evans, Norbert Schmitz, Ridha Joober, Ashok Malla

Can J Psychiatry. 2009;54(1):28–35

 

GRATIS 5 - A Comparison of Ziprasidone and Risperidone in the Long-Term Treatment of Schizophrenia: A 44-Week, Double-Blind, Continuation Study

Donald E Addington, Alain Labelle, Jayashri Kulkarni, Gordon Johnson, Antony Loebel, Francine S Mandel

Can J Psychiatry. 2009;54(1):46–54

 

3! - Disturbed Homeostasis in Patients with Acute Psychosis
Kotaro Hatta, Chie Usui and Hiroyuki Nakamura

Current Psychiatry Reviews. Volume 4, Number 4, November 2008

.

Regresar a RESÚMENES ENERO 2009